Patents
Patents for C07D 231 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings (25,550)
08/2009
08/26/2009EP2091944A2 Substituted bicyclocarboxyamide compounds
08/26/2009EP2091922A2 2-[1-phenyl-5-hydroxy-4alpha-methyl-hexahydrocyclopenta[f]indazol-5-yl]ethyl phenyl derivatives as glucocorticoid receptor ligands
08/26/2009EP2091920A2 Substituted pyrazoles, compositions containing these, method of production and use
08/26/2009CN101516839A Compounds which modulate the cb2 receptor
08/26/2009CN100532377C Compound containing tetrazine polynitrobenzene and synthesis method thereof
08/26/2009CN100532364C 5-substituted-alkylaminopyrazole derivatives as pesticides
08/26/2009CN100532363C Novel substituted pyrazole derivative, process for producing the same, and herbicidal composition containing the same
08/25/2009US7579469 For therapy of disease characterized by inflammatory, allergic, or proliferative processes
08/25/2009US7579347 Vanilloid receptor ligands and their use in treatments
08/25/2009US7579346 Carboxamides
08/25/2009CA2505086C Ophthalmic compositions for treating ocular hypertension
08/25/2009CA2366932C Cyclic protein tyrosine kinase inhibitors
08/20/2009WO2009101966A1 Palladium metal complex
08/20/2009WO2009101082A1 Substituted sulfonic acid amide compounds
08/20/2009WO2009100536A1 Inhibitors of kinase activity with 1,2-di-cyclyl substituted alkyne structures
08/20/2009WO2009037244A3 5-aryl-4,5-dihydro-(1h)-pyrazoles as cannabinoid cb1 receptor agonists
08/20/2009US20090209769 Alkyl-Analide Producing Method
08/20/2009US20090209530 Inhibitors of cyclin-dependent kinases, compositions and uses related thereto
08/19/2009EP2090568A1 Metal complex, luminescent device and display apparatus
08/19/2009EP2089385A2 Inhibitors of hepatitis c virus
08/19/2009EP2089367A1 Pyrazoline compounds as mineralocorticoid receptor antagonists
08/19/2009EP2089355A2 Modulators of glucocorticoid receptor, ap-1, and/or nf- kappa b activity and use thereof
08/19/2009EP1718617B1 3-substituted 1,5-diphenylpyrazole derivatives useful as cb1 modulators
08/19/2009EP1513802B1 Alpha-sulfonylamino-acetonitriles
08/19/2009EP1137639B1 Control of arthropods in animals
08/19/2009CN101511795A 1-aryl-5-alkyl pyrazole derivative compounds, processes of making and methods of using thereof
08/19/2009CN101511783A N-biaryl (hetero) arylsulphonamide derivatives useful in the treatment of diseases mediated by lymphocytes interactions
08/19/2009CN100528845C Pyrazolyl arync
08/19/2009CN100528153C Percutaneous absorption type cerebral protective agent
08/18/2009US7576245 Using a fluorinated phenyl compound containing electrophilic and nucleophilic groups; increasing the fluorous nature of an organic compound; 4-(1H,1H,2H,2H-Perfluorodecyl)benzenesulfonamide; N-[4-(1H,1H,2H,2H-perfluorodecyl)benzyloxycarbonyloxy]succinimide
08/18/2009US7576116 PDK-1/Akt signaling inhibitors
08/18/2009US7576115 1-methyl,3-alkaminothiocarbonylhydrazonomethyl,4-hydroxy,5-phenyl pyrazole; low-molecular-weight, nonpeptidic thrombopoietin receptor agonist; oral administration; bioavailability; blood disorders; platelet-increasing agents; angiogenesis; arteriosclerosis; blood/stem cell stimulant; thrombocytopenia
08/18/2009US7576112 Therapeutic N-aryl or N-heteroaryl pyrazolidine and pyrazolidinone derivatives
08/18/2009US7576107 1-(2,6-dichloro-4-trifluoromethylphenyl)-3-cyano-5-(2-methoxyethylamino)4-trifluoromethylsulfonylpyrazole; insecticides; widen the spectrum of the pesticides; control of parasites in animals
08/18/2009US7576087 3-(Phenylsulfonyl)-7-piperazin-1-yl-1H-pyrazolo[4,3-b]pyridine; 5-HT receptor subtype 5HT6; selective serotonin receptor antagonist; cognition actiators; alzheimer's disease; attention deficit disorder; antidepressant; antiepileptic agent; anxiolytic agents; obsessive compulsive disorder; Parkinson's
08/18/2009US7576072 Heterocyclic inhibitors of MEK and methods of use thereof
08/18/2009US7576064 Pyrazole derivative, drug composition containing the same and production intermediate therefor
08/18/2009US7576063 prevention or treatment of disease associated with hyperglycemia: diabetes, impaired glucose tolerance, impaired fasting glycemia, diabetic complications or obesity; e.g. 4-[(4-{3-[1-carbamoyl-1-(methyl)-ethylcarbamoyl]propyl}-2-methylphenyl)methyl]-3-( beta -D-glucopyranosyloxy)-5-isopropyl-1H-pyrazole
08/18/2009CA2549479C Substituted arylpyrazoles as parasiticidal agents
08/13/2009WO2009098501A1 Novel crystalline forms of 4- [4- (2-adamantylcarbam0yl) -5-tert-butyl-pyrazol-1-yl] benzoic acid
08/13/2009WO2009098257A1 Composition for dyeing keratin fibres comprising at least one cationic diamino-n,n-dihydropyrazolone derivative
08/13/2009WO2009097709A1 Pyrazolopyrimidinone-containing phenyl guanidine derivatives, pharmaceutical compositions containing them, process for their preparation and their use
08/13/2009WO2009041705A9 5-membered heterocyclic compounds as proton pump inhibitors
08/13/2009WO2009003719A3 Indane-amine derivatives, their preparation and use as medicaments
08/13/2009US20090203691 such as N1-{3-[3,5-Di(trifluoromethyl)phenyl]-1H-5-indazolyl}-(2R)-2-amino-3,3-diphenylpropanamide, having an excellent Jun N-terminal Kinase (JNK) inhibitory action, used for treating various immunologic diseases, inflammatory diseases, and/or neurodegenerative diseases
08/13/2009CA2713409A1 Novel crystalline forms of 4- [4- (2-adamantylcarbam0yl) -5-tert-butyl-pyrazol-1-yl] benzoic acid
08/12/2009EP2088136A1 Process for production of hydroxyadamantaneamine
08/12/2009EP2086999A1 Inhibitors for disrupting the interaction of ubiquitination related enzymes and uses thereof
08/12/2009EP2086967A2 Inhibitors of hepatitis c virus
08/12/2009EP2086942A2 Novel compounds
08/12/2009EP1931348A4 Monocyclic and bicyclic compounds and methods of use
08/12/2009EP1902033B1 Method for producing carboxamides
08/12/2009EP1819681B1 7-(2h-pyrazol-3-yl)-3,5-dihydroxy-heptanoic acid derivatives as hmg co-a reductase inhibitors for the treatment of lipidemia
08/12/2009EP1429771B1 Bicyclic compounds as inhibitors of chemokine binding to us28
08/12/2009CN101506173A Process for preparing 3-dihalomethylpyrazole-4-carboxylic acid derivatives
08/12/2009CN101506166A Substituted 1-(azolin-2-yl)-amino-2-aryl-1-hetaryl-ethane compounds
08/12/2009CN101506160A Positively charged water-soluble prodrugs of aryl- and heteroarylacetic acids with very fast skin penetration rate
08/12/2009CN101505747A Pyrazinones as cellular proliferation inhibitors
08/11/2009US7572922 Substituted pyrazoles, compositions containing such compounds and methods of use
08/11/2009US7572806 PPAR active compounds
08/11/2009US7572787 Substituted naphthalene sulfonamides
08/11/2009CA2537410C Ophthalmic indazole comprising compositions for treating ocular hypertension
08/06/2009WO2009096555A1 Method for producing compound having deuterated aromatic ring or heterocyclic ring
08/06/2009WO2008151719A3 3-cyclopropyl-4-(3-thiobenzoyl)pyrazoles and their use as herbicides
08/06/2009US20090197935 Primary amines and derivatives thereof as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
08/06/2009US20090197925 O-cyclopropyl-carboxanilides and their use
08/06/2009US20090197886 Hexahydro-cycloheptapyrazole cannabinoid modulators
08/06/2009US20090197882 Indazole derivatives for the treatment of hsp90-induced diseases
08/05/2009EP2085391A2 Inhibitors of factor XA and other serine proteases involved in the coagulation cascade
08/05/2009EP2084137A1 Process for the sulfinylation of a pyrazole derivative
08/05/2009EP2084136A1 Benzoylpyrazole compounds, process for their production and herbicides containing them
08/05/2009EP2084135A2 Pyrazole compounds
08/05/2009EP2084127A1 Diaryl, dipyridinyl and aryl-pyridinyl derivatives and uses thereof
08/05/2009EP2083816A2 Heterocyclic amide compounds useful as kinase inhibitors
08/05/2009EP1699454B1 Pyrazole derivatives and use thereof as orexin receptor antagonists
08/05/2009EP1531822B1 1-aryl-4-substituted piperazine derivatives for use as ccr1 antagonists for the treatment of inflammation and immune disorders
08/05/2009EP1383731B1 Biaryl compounds as serine protease inhibitors
08/05/2009EP1249233B9 Npyy5 antagonists
08/05/2009CN101501003A Phenyl-pyrazole derivatives as non-steroidal glucocoricoid receptor ligands
08/05/2009CN101501002A Non-nucleoside reverse transcriptase inhibitors
08/05/2009CN101497585A Method for photocatalytic synthesis of 1,3,5-trisubstituted-2-pyrazole derivative
08/05/2009CN100522958C Preparation and use of 2-substituted-5-oxo-3- pyrazolidinecarboxylates
08/05/2009CN100522952C Insecticidal phthalamide derivatives
08/05/2009CN100522948C Isopentyl carboxanilides for combating undesired micro-organisms
08/05/2009CN100522947C CCK-1 receptor modulators
08/05/2009CN100522937C Anthranilic acid amides, method for the production thereof, their use as antiarrhythmia agents, and pharmaceutical preparations thereof
08/04/2009US7569592 Heteroaryl substituted pyrazole modulators of metabotropic glutamate receptor-5
08/04/2009US7569519 Such as 2-(2-chloro-3-(3-tetrahydrofuranyl)oxymethyl-4-methylsulfonyl-benzoyl)cyclohexane-1,3-dione; for selectively controlling broad-leaved weeds and weed grasses in crops such as rice
08/04/2009US7569517 4-biphenyl-substituted pyrazolidin-3 5-diones pesticide agent and/or microbicide and/or herbicide
08/04/2009US7569516 5-substituted-1-arylpyrazole-3-carboxylic acid derivatives
07/2009
07/30/2009WO2009093537A1 Fluorescent agent having ethynyl group
07/30/2009WO2009092276A1 Bicyclo-substituted pyrazolon azo derivatives, preparation process and pharmaceutical use thereof
07/30/2009WO2009067600A3 Biaryl pde4 inhibitors for treating inflammation
07/30/2009US20090192208 5-Phenoxypyrazoles where the phenyl is 4-substituted with p-allyloxyphenoxy- p-allyloxyphenylthio- or p-allyloxyphenylalkylidene-; p-hydroxyphenyl intermediates; controlling noxious arthropod pests in households, agriculture and forestry
07/30/2009US20090192192 Inhibitors of biofilm formation of gram-positive and gram-negative bacteria
07/30/2009US20090192172 2-Alkyl-Cycloalk(en)yl-Carboxamides
07/30/2009US20090192136 Benzoyl-piperazine derivatives
07/30/2009US20090192122 Inflammatory cytokine release inhibitor
07/30/2009CA2711535A1 Bicyclo-substituted pyrazolon azo derivatives, preparation process and pharmaceutical use thereof
07/29/2009EP2082743A2 Inhibitors of GSK-3 and crystal structures of GSK-3beta protein and protein complexes
1 ... 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 ... 256